Cartilage T2 Mapping
QUIBIM
Product specifications |
Information source:
Vendor
Last updated: March 10, 2020 |
General | |
---|---|
Product name | Cartilage T2 Mapping |
Company | QUIBIM |
Subspeciality | MSK |
Modality | MR |
Disease targeted | Osteoarthritis, Inflammatory disease, Cartilage quality, Degenerative disease, Sports-related diseases and conditions |
Key-features | Automatic cartilage segmentation, T2 Values |
Suggested use | Without interference of a radiologist: AI-only diagnosis |
Data characteristics | |
Population | Patients with degenerative or inflammatory diseases of the joints |
Input | MR 3D T2 Gradient Echo with high contrast between bone and cartilage T2 Multi-echo |
Input format | |
Output | One-page structured report: 3D reconstruction of the femoral cartilage, T2 cartilage histogram, T2 values per parcel |
Output format | DICOM Secondary Capture / PDF |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
|
FDA
|
No or not yet |
Market presence | |
On market since | 01-2019 |
Distribution channels | |
Countries present (clinical, non-research use) | 2 |
Paying clinical customers (institutes) | 5+ |
Research/test users (institutes) | <5 |
Pricing | |
Pricing model | License |
Based on | Number of installations, Number of analyses |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |